Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathological Conditions, Anatomical » Atrophy
Description
Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. MeSH
Hierarchy View
Subtype Terms (1)
Muscular Atrophy
36 drugs (16 approved, 20 experimental)
Approved Indicated Drugs (4)
Phase 3 Indicated Drugs (8)
Phase 2 Indicated Drugs (8)
Other Experimental Indicated Drugs (5)
Organization Involved with Phase 4 Indications (46)
Organization Involved with Phase 3 Indications (96)
ABC Foundation School of Medicine
All India Institute of Medical Sciences
Center for Vulvovaginal Disorders
Competence Network on Parkinson's Disease
Comprehensive Clinical Trials, LLC
Deutsche Parkinson Vereinigung
German Center for Neurodegenerative Diseases (DZNE)
German Parkinson Study Group (GPS)
Horizons Clinical Research Center, LLC
Hospital Universitario Central de Asturias
Laboratório Teuto Brasileiro S/A
Lawrence OB/GYN Clinical Research, LLC
National Center for Advancing Translational Science (NCATS)
National Institute of Neurological Disorders and Stroke (NINDS)
Northern California Research Corp
Novum Pharmaceutical Research Services
OB-GYN Associates of Mid Florida
ParkinsonFonds Deutschland gGmbH
Pharmaceutical Research Associates, Inc. (PRA)
Physician Care Clinical Research LLC
Organization Involved with Phase 2 Indications (104)
Assistance Publique - Hôpitaux de Paris
Bambino Gesù Hospital and Research Institute
Carlo Besta Neurological Institute
Catalyst Pharmaceuticals, Inc.
Childrens Hospital of Eastern Ontario
Hammersmith Medicines Research
Hoosier Cancer Research Network
Icahn School of Medicine at Mount Sinai
Mashhad University of Medical Sciences
National Institutes of Health (NIH)
Norwegian University of Science and Technology
Oregon Health and Science University
Regenerative Patch Technologies
Royal Liverpool & Broadgreen University Hospitals NHS Truts
Shahid Beheshti University of Medical Sciences
Slocum Center for Orthopedics and Sports Medicine
Slocum Research and Education Foundation
Snyder, Robert W., M.D., Ph.D., P.C.
Organization Involved with Phase 1 Indications (32)
Organization Involved with Other Experimental Indications (48)
Autonomous University of Barcelona
China Academy of Chinese Medical Sciences
Federal University of Sao Paulo
Foundation for Female Health Awareness
Fundação de Amparo à Pesquisa do Estado de São Paulo
Guangdong Provincial Hospital of Traditional Chinese Medicine
Jack Hughston Memorial Hospital
Liaoning Hospital of Traditional Chinese Medicine
Postgraduate Institute of Medical Education and Research
Shaanxi University of Chinese Medicine
Shanxi College of Traditional Chinese Medicine
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
